Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis

Published:2018-05 Issue:5 Volume:83 Page:902-914
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Cramer Stig P.¹,Simonsen Helle J.¹,Varatharaj Aravinthan²,Galea Ian²,Frederiksen Jette L.³⁴,Larsson Henrik B. W.¹⁴

Affiliation:

1. Functional Imaging Unit, Department of Clinical Physiology; Nuclear Medicine, and PET, Rigshospitalet; Copenhagen Denmark

2. Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine; University of Southampton; Southampton United Kingdom

3. Department of Neurology; Rigshospitalet; Glostrup Denmark

4. Institute of Clinical Medicine, Faculty of Health and Medical Science; Copenhagen University; Copenhagen Denmark

Funder

Research Foundation of the Capital Region of Denmark

Foundation for Health Research

Danish Council for Independent Research

Rigshospitalets forskningspuljer

Danish Multiple Sclerosis Society

Biogen Idec

Biogen

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference48 articles.

1. Multiple sclerosis: current treatment algorithms;Río;Curr Opin Neurol,2011

2. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin;Yednock;Nature,1992

3. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1;Matloubian;Nature,2004

4. Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS;Kowarik;Neurology,2011

5. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N Engl J Med,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the hidden connection: the blood-brain barrier’s role in epilepsy;Frontiers in Neurology;2024-08-14

2. Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies;International Journal of Molecular Sciences;2023-11-14

3. Teriflunomide Promotes Blood–Brain Barrier Integrity by Upregulating Claudin-1 via the Wnt/β-catenin Signaling Pathway in Multiple Sclerosis;Molecular Neurobiology;2023-10-11

4. Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosis;Multiple Sclerosis and Related Disorders;2022-07

5. Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview;Pharmaceutics;2021-10-26